185 related articles for article (PubMed ID: 6090848)
1. Inhibition of prolactin and growth hormone secretion by nickel.
Carlson HE
Life Sci; 1984 Oct; 35(17):1747-54. PubMed ID: 6090848
[TBL] [Abstract][Full Text] [Related]
2. Verapamil: influence upon basal and stimulated rat growth hormone and prolactin release in vitro.
Stachura ME
Proc Soc Exp Biol Med; 1983 May; 173(1):109-17. PubMed ID: 6134290
[TBL] [Abstract][Full Text] [Related]
3. In vitro pituitary GH secretion after GHRH, forskolin, dibutyryl cyclic-adenosine 3',5'-monophosphate and phorbol 12-myristate 13-acetate stimulation in long-term orchidectomized rats.
Tena-Sempere M; Pinilla L; Aguilar E
J Mol Endocrinol; 1996 Feb; 16(1):81-8. PubMed ID: 8672236
[TBL] [Abstract][Full Text] [Related]
4. Cortisol inhibition of growth hormone-releasing hormone-stimulated growth hormone release from cultured sheep pituitary cells.
Sartin JL; Kemppainen RJ; Coleman ES; Steele B; Williams JC
J Endocrinol; 1994 Jun; 141(3):517-25. PubMed ID: 8071650
[TBL] [Abstract][Full Text] [Related]
5. GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin.
García-Tornadú I; Rubinstein M; Gaylinn BD; Hill D; Arany E; Low MJ; Díaz-Torga G; Becu-Villalobos D
J Endocrinol; 2006 Sep; 190(3):611-9. PubMed ID: 17003262
[TBL] [Abstract][Full Text] [Related]
6. Altered responsiveness to hypophysiotrophic hormones of perifused rat pituitary tumours.
Carlson HE; Mariz IK; Briggs JE; Daughaday WH
Acta Endocrinol (Copenh); 1977 Mar; 84(3):512-22. PubMed ID: 190840
[TBL] [Abstract][Full Text] [Related]
7. Effects of growth hormone-releasing factor, somatostatin and dopamine on growth hormone and prolactin secretion from cultured ovine pituitary cells.
Law GJ; Ray KP; Wallis M
FEBS Lett; 1984 Jan; 166(1):189-93. PubMed ID: 6141070
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone and prolactin secretion by dispersed cell cultures of a normal human pituitary: effects of thyrotrophin releasing hormone, theophylline, somatostatin, and 2-bromo-alpha-ergocryptine.
Adams EF; Brajkovich IE; Mashiter K
Acta Endocrinol (Copenh); 1981 Nov; 98(3):345-51. PubMed ID: 6117169
[TBL] [Abstract][Full Text] [Related]
9. On the involvement of cyclic AMP and extracellular Ca2+ in the regulation of hormone release from rat pituitary tumour (GH3) cells in culture.
Sletholt K; Haug E; Gautvik KM
Biosci Rep; 1987 Feb; 7(2):93-105. PubMed ID: 2443198
[TBL] [Abstract][Full Text] [Related]
10. Relative importance of newly synthesized and stored hormone to basal secretion by growth hormone and prolactin cells.
Chen TT; Kineman RD; Betts JG; Hill JB; Frawley LS
Endocrinology; 1989 Oct; 125(4):1904-9. PubMed ID: 2507285
[TBL] [Abstract][Full Text] [Related]
11. In vitro control of prolactin (PRL) and growth hormone secretion of neonatal rat pituitary glands: effects of ovine PRL, salmon calcitonin, endothelin-3, angiotensin II, bromocryptine and somatostatin.
Kacsóh B; Tóth BE; Avery LM; Grosvenor CE
Life Sci; 1993; 52(3):259-69. PubMed ID: 8093804
[TBL] [Abstract][Full Text] [Related]
12. Pituitary immediate release pools of growth hormone and prolactin are preferentially refilled by new rather than stored hormone.
Stachura ME; Tyler JM; Kent PG
Endocrinology; 1989 Jul; 125(1):444-9. PubMed ID: 2544408
[TBL] [Abstract][Full Text] [Related]
13. Human pancreatic growth hormone-releasing factor-44 differentially stimulates release of stored and newly synthesized rat growth hormone in vitro.
Stachura ME; Tyler JM; Farmer PK
Endocrinology; 1985 Feb; 116(2):698-706. PubMed ID: 2981674
[TBL] [Abstract][Full Text] [Related]
14. Effects of theophylline infusion on the growth hormone (GH) and prolactin response to GH-releasing hormone administration in acromegaly.
Losa M; Alba-Lopez J; Schopohl J; Sobiesczcyk S; Chiodini PG; Müller OA; von Werder K
J Endocrinol Invest; 1988 Oct; 11(9):663-7. PubMed ID: 3146595
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone and prolactin secretion in cultured somatomammotroph cells.
Kashio Y; Chomczynski P; Downs TR; Frohman LA
Endocrinology; 1990 Sep; 127(3):1129-35. PubMed ID: 1974845
[TBL] [Abstract][Full Text] [Related]
16. Effects of trifluoperazine on rat prolactin, growth hormone, thyroid stimulating hormone and adrenocorticotrophin secretion in vitro.
Powell RC; Daniels M; Innes GK; Ashby MJ; Mashiter K
Acta Endocrinol (Copenh); 1983 Aug; 103(4):492-6. PubMed ID: 6310921
[TBL] [Abstract][Full Text] [Related]
17. Somatostatin inhibits basal and vasoactive intestinal peptide-stimulated hormone release by different mechanisms in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1551-8. PubMed ID: 6138245
[TBL] [Abstract][Full Text] [Related]
18. Fractional reduction of somatostatin concentration interacted with rat growth hormone releasing hormone to titrate the magnitude of pulsatile growth hormone and prolactin release in perifusion.
Stachura ME; Tyler JM; Farmer PK
Neuroendocrinology; 1988 Nov; 48(5):500-6. PubMed ID: 2907614
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptide.
Doi N; Hirotani C; Ukai K; Shimada O; Okuno T; Kurasaki S; Kiyofuji T; Ikegami R; Futamata M; Nakagawa T; Ase K; Chihara K
Arzneimittelforschung; 2004; 54(12):857-67. PubMed ID: 15646370
[TBL] [Abstract][Full Text] [Related]
20. Cofactor requirements for the stimulation of ox growth hormone release in vitro.
Kerbey AL; McPherson M; Sheterline P; Schofield JG
Symp Soc Exp Biol; 1974; (28):375-97. PubMed ID: 4375863
[No Abstract] [Full Text] [Related]
[Next] [New Search]
